Phosphatase inhibition intracoronary gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Phosphatase inhibition intracoronary gene therapy, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure [Phase 2]